Ptc Therapeutics (PTCT) Gross Profit Growth (3y) (2019 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) Gross Profit Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 77.42% |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 28.75% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 45.27% |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 59.77% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 80.79% |
| 10 | Ptc Therapeutics | 5.81 Bn | 3.58 Bn | 340.60 Mn | 19.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.20% |
| Mar 31, 2026 | 5.84% |
| Dec 31, 2025 | 0.26% |
| Sep 30, 2025 | -1.31% |
| Jun 30, 2025 | 2.41% |
| Mar 31, 2025 | 103.22% |
| Dec 31, 2024 | 8.09% |
| Sep 30, 2024 | 12.04% |
| Jun 30, 2024 | 16.12% |
| Mar 31, 2024 | 21.53% |
| Dec 31, 2023 | 39.50% |
| Sep 30, 2023 | 18.04% |
| Jun 30, 2023 | 42.20% |
| Mar 31, 2023 | 47.57% |
| Dec 31, 2022 | 26.20% |
| Sep 30, 2022 | 43.73% |
| Jun 30, 2022 | 23.72% |
| Mar 31, 2022 | 39.36% |
| Dec 31, 2021 | 23.85% |
| Sep 30, 2021 | 38.01% |